Asia Pacific Personalized Medicine Outsourcing Market Size & Outlook

The personalized medicine outsourcing market in Asia Pacific is expected to reach a projected revenue of US$ 59,277.0 million by 2030. A compound annual growth rate of 13.3% is expected of Asia Pacific personalized medicine outsourcing market from 2024 to 2030.
Revenue, 2023 (US$M)
$24,692.5
Forecast, 2030 (US$M)
$59,277.0
CAGR, 2024 - 2030
13.3%
Report Coverage
Asia Pacific

Asia Pacific personalized medicine outsourcing market, 2018-2030 (US$M)

Asia

Asia Pacific personalized medicine outsourcing market highlights

  • The Asia Pacific personalized medicine outsourcing market generated a revenue of USD 24,692.5 million in 2023.
  • The market is expected to grow at a CAGR of 13.3% from 2024 to 2030.
  • In terms of segment, clinical was the largest revenue generating phase in 2023.
  • Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.


Asia Pacific data book summary

Market revenue in 2023USD 24,692.5 million
Market revenue in 2030USD 59,277.0 million
Growth rate13.3% (CAGR from 2023 to 2030)
Largest segmentClinical
Fastest growing segmentClinical
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationClinical
Key market players worldwidePAREXEL, Syneos Health, Catalent Inc, Icon PLC, Lonza Group Ltd, Syngene, HCL Technologies, Infosys Ltd ADR, Aurigene Pharmaceutical Services


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 24.3% of the global personalized medicine outsourcing market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 59,277.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Personalized Medicine Outsourcing Market Scope

Personalized medicine outsourcing market segmentation & scope
Phase II
Phase III
Phase IV
Preclinical
Application
Oncology
Rare Diseases
Infectious Diseases
Others
Service
Contract Manufacturing
Contact Development
Type
Inhibitor Drugs
Monoclonal Antibodies
Cell & Gene Therapy
Others
End Use
Pharmaceutical Companies
Biotechnology Companies
Others
Countries
U.S.
Canada
Mexico
Germany
UK
France
Italy
Spain
Denmark
Norway
Sweden
China
Japan
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait

Personalized Medicine Outsourcing Market Companies

Name Profile # Employees HQ Website

Asia Pacific personalized medicine outsourcing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized medicine outsourcing market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific personalized medicine outsourcing market based on clinical covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Asia Pacific personalized medicine outsourcing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific personalized medicine outsourcing market databook

  • Our clientele includes a mix of personalized medicine outsourcing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific personalized medicine outsourcing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific personalized medicine outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific personalized medicine outsourcing market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more